TRANSFUSION-DEPENDENT THALASSEMIA
Clinical trials for TRANSFUSION-DEPENDENT THALASSEMIA explained in plain language.
Never miss a new study
Get alerted when new TRANSFUSION-DEPENDENT THALASSEMIA trials appear
Sign up with your email to follow new studies for TRANSFUSION-DEPENDENT THALASSEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy aims to free patients from lifelong blood transfusions
⭐️ CURE ⭐️ Recruiting nowThis study follows people who have already received an experimental gene therapy called BRL-101 for transfusion-dependent β-thalassemia, a severe blood disorder requiring regular transfusions. Researchers will monitor participants over the long term to check for safety issues, su…
Matched conditions: TRANSFUSION-DEPENDENT THALASSEMIA
Sponsor: Bioray Laboratories • Aim: ⭐️ CURE ⭐️
Last updated Jul 23, 2026 00:00 UTC
-
CRISPR stem cell therapy could end transfusions for sickle cell and thalassemia patients
Disease control Recruiting nowThis study tests a one-time treatment called CTX001, which uses CRISPR gene editing to modify a patient's own stem cells to produce more fetal hemoglobin. The goal is to reduce or eliminate the need for blood transfusions in people with transfusion-dependent beta-thalassemia or s…
Matched conditions: TRANSFUSION-DEPENDENT THALASSEMIA
Phase: PHASE3 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC